Levetiracetam Kent (Levetiracetam)

Levetiracetam exerts its antiepileptic effect by binding to the synaptic vesicle protein SV2A. This binding modulates neurotransmitter release, stabilizes neuronal membranes, and reduces abnormal neuronal excitability, thereby helping to prevent seizure initiation and propagation.

The appropriate dose of Levetiracetam Kent is determined by the prescribing clinician based on the patient’s age, weight, renal function, seizure type, and overall clinical condition. Dosage adjustments are made individually and are not standardized in product literature.

Safety data for levetiracetam during pregnancy and lactation are limited. Clinicians must weigh the potential benefits for seizure control against any possible risks to the fetus or infant. Consultation with a specialist is recommended before use in pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers or GABA‑enhancers. It generally has fewer drug‑enzyme interactions, a rapid onset when given intravenously, and a favorable tolerability profile, making it a useful alternative or adjunct in many seizure management regimens.

Levetiracetam Kent should be stored at 2‑8 °C in a refrigerator. Keep the product in its original packaging, protect it from light, and avoid freezing or shaking the solution to maintain stability.

Levetiracetam Kent is administered by intravenous infusion under the supervision of qualified healthcare professionals. The infusion rate and duration are determined by the prescriber, typically based on the clinical situation and patient tolerance.

Serious risks include severe allergic reactions (such as rash, swelling, or breathing difficulty), significant mood changes including depression or suicidal thoughts, and rare blood disorders like thrombocytopenia. Prompt medical attention is required if any of these events occur.

Levetiracetam Kent should be avoided in patients with known hypersensitivity to levetiracetam or any component of the formulation. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications that could compromise safety.